• Magazine
    • Past Issues
    • Subscribe
    • Change Mailing Address
    • Surveys
    • Guidelines for Authors
    • Editorial Calendar
    • Editorial Deadlines
  • Practice
    • Business Tips
    • Chiropractic Schools
    • Clinical & Technique
    • eBooks
    • eCourses
    • Infographics
    • Quizzes
    • Wellness & Nutrition
    • Personal Growth
    • Podcast
  • Resource Centers
  • Products & Services
    • Buyer’s Guide
    • Products Directory
    • Submit a Product
    • Vendor Login
  • Datebook
    • Become an Events Poster
    • Post an Event
    • View Events
  • Jobs
    • Jobs
    • Post a Job
  • Advertise
    • Advertising Information
    • Media Kit
    • Contact Us
    • Upload Advertising

Your Online Chiropractic Community

Chiropractic Economics Your Online Chiropractic Community
Subscribe
  • Home
  • Current Issue
  • News
  • Webinars
  • Chiropractic Research
  • Students
  • Coronavirus (COVID-19)

Bipartisan legislation proposed for national CBD use

Chiropractic Economics September 8, 2020

The Hemp and Hemp Derived CBD Consumer Protection and Market Stabilization Act of 2020 was proposed on Sept. 4, 2020, with support from U.S. Congress members Kurt Schrader (D-OR) and Morgan Griffith (R-VA), directing the U.S. Food and Drug Administration (FDA) to set a clear regulatory framework for hemp and hemp-derived CBD use in the U.S.

The U.S. is currently a patchwork of state regulation, some of which allow hemp and CBD, some of which specifically do not, and some that more of less turn a blind eye to some sales and usage. Since the introduction of the 2018 Farm Bill that allowed states to legalize hemp products the hemp industry has called on congress to provide wide-ranging FDA statutory authority for hemp regulation.

The market for CBD and hemp supplements grew rapidly in 2018-2019, but many products, especially food consumables, are viewed as illegal by the FDA and many states.

“Hemp was historically an important crop for Virginia farmers, and dietary supplements made from it do not possess dangerous addictive qualities,” Griffith said in a statement. “Nevertheless, the current state of regulation creates confusion about its legal uses. I joined this bipartisan bill to provide certainty for hemp farmers that their crop may find legal uses.”

According to Nutraceuticals World, four dietary supplement industry trade associations — the American Herbal Products Association (AHPA), Council for Responsible Nutrition (CRN), the United Natural Products Alliance (UNPA), and the Consumer Healthcare Products Association (CHPA) — have all expressed support for new legislation.

The industry is seeking legislation that would ensure that products derived from industrial hemp have a clear regulatory pathway to market, and that consumer-grade food and dietary supplement products can be sold with FDA approval.

This year CBD sales are projected to grow 14% compared to 2019 for a total of $4.7 billion in sales according to Brightfield Group, a CBD and cannabis comprehensive data company based in Illinois.

Trade organizers say the hemp/CBD boom is being stifled by the regulatory uncertainty.

“While the 2018 Farm Bill changed the law to allow hemp farming, regulatory uncertainty remains about the inclusion of hemp and hemp-derived CBD in dietary supplements,” the trade organizations said in a statement. “This lack of regulatory clarity along with insufficient oversight around hemp and hemp-derived CBD exposes consumers to potentially unsafe products and lack of consistency in product quality.”

Champion Hemp Farms in Champion, Penn., has seen a 240% increase in online sales since the COVID pandemic began according to the Pittsburgh Post-Gazette.

The FDA this year also reopened a public comment period on CBD regulation, and draft enforement guidelines have been submitted to the White House.

The new hemp legislation would mandate that “cannabidiol derived from hemp, and any other ingredient derived from hemp shall be lawful under the Federal Food, Drug and Cosmetic Act (21 U.S.C. 301 et seq.) as a dietary ingredient in a dietary supplement.”

Related Posts

  • CBD public hearing announced by U.S. Food and Drug AdministrationCBD public hearing announced by U.S. Food and Drug Administration
  • CBD news: FDA fast-tracking CBD food, drinks for 2020CBD news: FDA fast-tracking CBD food, drinks for 2020
  • CBD offerings by chiropractors rise more than 5% according to new 2020 surveyCBD offerings by chiropractors rise more than 5% according to new 2020 survey
  • The top 3 considerations for finding the best CBD for patientsThe top 3 considerations for finding the best CBD for patients
  • Cannabidiol can help your patients and your practiceCannabidiol can help your patients and your practice
  • As FDA investigates CBD, recent omega-3 ruling may have impactAs FDA investigates CBD, recent omega-3 ruling may have impact

Filed Under: Industry News, News

Current Issue

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube logoYouTube logoYouTube

820 A1A N Highway W18,

Ponte Vedra Beach, FL 32082

Phone 904.285.6020

Fax 904.395.9118

CONTACT US »

Privacy Policy & Terms of Service

Copyright © 2021, All Rights Reserved

SUBSCRIBE TO THE MAGAZINE

Get Chiropractic Economics magazine
delivered to your home or office. Just
fill out our form to request your FREE
subscription for 20 issues a year,
including two annual Buyers Guides.

SUBSCRIBE NOW »

Latest Chiropractic News

  • Shock Wave Technology provider debuts new name: Kinas Medical Technologies
  • Troy Healthcare debuts clinically-validated topical migraine and headache formula
  • Colorado allows chiropractors to give COVID-19 vaccine shots
x